Table 2. Clustering of up- or downregulated genes to determine biological pathways affected by edelfosine in human CD4+ T cells after gene expression analysis.
A Setting: unstimultated + 10 µg/ml edelfosine vs. unstimulated | ||
Up | Gene Examples | P-value |
Apoptosis | JUN, RHOB, KRAS | 1.8×10−2 |
Programmed cell death | JUN, RHOB, KRAS | 1.9×10−2 |
Learning | JUN, KRAS | 2.2×10−2 |
Down | Gene Examples | P-value |
Immune response | CD74, CD79A, IGJ, IRF8, CCL22 | 3.9×10−14 |
Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | CD74, IFI30, HLA-DMA, HLA-DPA1 | 2.2×10−11 |
Antigen processing and presentation | CD74, IFI30, HLA-DMB, HLA-DRA | 1.3×10−8 |
(A) The incubation of unstimulated cells with 10 µg/ml edelfosine resulted in the upregulation of apoptosis- and cell death-associated genes. Genes involved in immune response and antigen processing and presentation were downregulated. (B) In the case of stimulated cells which were cultured in presence of 3.3 µg/ml edelfosine the downmodulation of cell cycle progression-related genes was found. Additionally, edelfosine resulted in the upregulation of genes assigned to immune response- and virus response-pathways characterized by type I IFN-regulated genes.